HP
Heerma Peter
Directeur Commercial
OtherM
€945,030
▼ Sales (11 ops.)
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Heerma Peter, Directeur Commercial. Officer active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 22 disclosures have been logged. Split: 0 buy · 11 sells. Total volume traded: €945k. Activity tracked since 13 August 2021. The latest transaction was filed on 13 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Heerma Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
14,000 shares0Common StockSEC:0001789617-26-000002:0
7,215 shares@ US$41.92880.0054% mcap39.7% of flowCommon StockSEC:0001789617-26-000002:1
26,120 shares0Common StockSEC:0001789617-26-000001:0
4,980 shares@ US$40.0017.9% of flowCommon StockSEC:0001789617-25-000009:0
5,591 shares@ US$35.0021.8% of flowCommon StockSEC:0001789617-25-000007:0
2,662 shares@ US$30.0011.3% of flowCommon StockSEC:0001789617-25-000006:0
891 shares0Common StockSEC:0001789617-25-000004:0
4,920 sharesCommon StockSEC:0001415889-25-012057:0
8,000 sharesCommon StockSEC:0001415889-25-003821:0
21,500 shares0Common StockSEC:0001415889-25-003063:0
1,584 shares@ US$18.94087.4% of flowCommon StockSEC:0001415889-25-002001:0
6,750 shares0Common StockSEC:0001415889-24-023092:0
25,000 shares0Common StockSEC:0001415889-24-002282:0
1,559 shares@ US$9.06843.3% of flowCommon StockSEC:0001415889-24-001797:0
3,091 shares@ US$8.25116.3% of flowCommon StockSEC:0001209191-23-051885:0
20,250 shares0Common StockSEC:0001209191-23-006425:0
1,550 shares@ US$21.90448.0% of flowCommon StockSEC:0001209191-23-005031:0
3,042 shares@ US$25.6820.1% of flowCommon StockSEC:0001209191-22-053018:0
9,840 shares0Common StockSEC:0001209191-22-006363:0
1,875 shares@ US$24.984.4% of flowCommon StockSEC:0001209191-22-005082:0
3,058 shares@ US$24.76986.9% of flowCommon StockSEC:0001209191-21-059353:0
4,500 shares0Common StockSEC:0001209191-21-052085:0
About Heerma Peter
Heerma Peter is Directeur Commercial at Travere Therapeutics, Inc. The 22 filings recorded cover the period from 2021-08-17 to 2026-04-15 in the sampled filings, with sales of EUR 945030 and no purchases.